CO6280531A2 - Novedosos derivados de 1,3 - Google Patents
Novedosos derivados de 1,3Info
- Publication number
- CO6280531A2 CO6280531A2 CO10066630A CO10066630A CO6280531A2 CO 6280531 A2 CO6280531 A2 CO 6280531A2 CO 10066630 A CO10066630 A CO 10066630A CO 10066630 A CO10066630 A CO 10066630A CO 6280531 A2 CO6280531 A2 CO 6280531A2
- Authority
- CO
- Colombia
- Prior art keywords
- thienyl
- novedosos
- derived
- benzthiazolyl
- indanyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Gynecology & Obstetrics (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Abstract
1.- Un derivado representado por la Fórmula 1 o una sal farmacéuticamente aceptable del mismo:en donde R1 es un fenilo sustituido o insustituido; o un heterociclilo seleccionado de piridinilo, isoxazolilo, tiazolilo, pirimidinilo, indanilo, benztiazolilo, pirazolilo, tiadiazolilo, oxazolilo, piperidinilo, morfolinilo, imidazolilo, pirrolidinilo, tienilo, triazolilo, pirrolilo y furilo; R2 es dialquilamino C1-C6, o un heterociclilo sustituido o insustituido seleccionado de piridinilo, isoxazolilo, tiazolilo, pirimidinilo, indanilo, benztiazolilo, pirazolilo, tiadiazolilo, oxazolilo, piperidinilo, morfolinilo, imidazolilo, pirrolidinilo, tienilo, triazolilo, pirrolilo y furilo; y n es un número entero de 1 a 3.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20070111783 | 2007-11-02 | ||
KR1020080105439A KR101103118B1 (ko) | 2007-11-02 | 2008-10-27 | 신규한 1,3-디히드로-5-이소벤조퓨란카르보니트릴 유도체 화합물 및 이를 함유하는 조루증 치료용 약학조성물 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO6280531A2 true CO6280531A2 (es) | 2011-05-20 |
Family
ID=40855892
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO10066630A CO6280531A2 (es) | 2007-11-02 | 2010-06-02 | Novedosos derivados de 1,3 |
Country Status (20)
Country | Link |
---|---|
US (1) | US8242159B2 (es) |
EP (1) | EP2215070A4 (es) |
JP (1) | JP5281649B2 (es) |
KR (1) | KR101103118B1 (es) |
CN (1) | CN101910146A (es) |
AR (1) | AR069166A1 (es) |
AU (1) | AU2008319628B2 (es) |
BR (1) | BRPI0818267A2 (es) |
CA (1) | CA2703783C (es) |
CL (1) | CL2008003231A1 (es) |
CO (1) | CO6280531A2 (es) |
IL (1) | IL205350A0 (es) |
MX (1) | MX2010004727A (es) |
NZ (1) | NZ585091A (es) |
PE (1) | PE20091018A1 (es) |
RU (1) | RU2448963C2 (es) |
TW (1) | TWI365741B (es) |
UA (1) | UA99492C2 (es) |
WO (1) | WO2009057974A2 (es) |
ZA (1) | ZA201003794B (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013026455A1 (en) * | 2011-08-24 | 2013-02-28 | Aarhus Universitet | Permanently positively charged antidepressants |
US9169237B1 (en) * | 2014-10-24 | 2015-10-27 | Medi Synergics, LLC | Antiprotozoal amidine compounds |
KR101637177B1 (ko) * | 2014-03-14 | 2016-07-07 | 건일제약 주식회사 | 8-히드록시클로미프라민 또는 이의 약학적으로 허용가능한 염의 제조방법 |
ES2911910T3 (es) | 2015-02-11 | 2022-05-23 | Sunovion Pharmaceuticals Inc | Compuestos de 1-heterociclilisocromanilo y análogos para tratar trastornos del SNC |
CA3032141A1 (en) | 2016-07-29 | 2018-02-01 | Vadim ALEXANDROV | Compounds and compositions and uses thereof |
CN116514761A (zh) | 2016-07-29 | 2023-08-01 | 赛诺维信制药公司 | 化合物、组合物及其用途 |
US10780074B2 (en) | 2017-08-02 | 2020-09-22 | Sunovion Pharmaceuticals Inc. | Compounds and uses thereof |
CN109111415B (zh) * | 2018-10-25 | 2022-08-23 | 安徽中医药大学 | 一类石斛生物碱衍生物、制备方法和医药用途 |
EP3938045A1 (en) | 2019-03-14 | 2022-01-19 | Sunovion Pharmaceuticals Inc. | Salts of a isochromanyl compound and crystalline forms, processes for preparing, therapeutic uses, and pharmaceutical compositions thereof |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1526331A (en) * | 1976-01-14 | 1978-09-27 | Kefalas As | Phthalanes |
GB0105627D0 (en) * | 2001-03-07 | 2001-04-25 | Cipla Ltd | Preparation of phthalanes |
ATE326957T1 (de) * | 2001-03-16 | 2006-06-15 | Dmi Biosciences Inc | Verwendung von tramadol zur verzögerung der ejakulation |
JP2005510518A (ja) * | 2001-11-08 | 2005-04-21 | セプラコール, インク. | シタロプラムのデスメチル代謝産物及びジデスメチル代謝産物の濃縮された鏡像異性体を用いてうつ病及び他のcns障害を治療する方法 |
IN192863B (es) | 2001-11-13 | 2004-05-22 | Ranbaxy Lab Ltd | |
US6764200B1 (en) * | 2003-01-15 | 2004-07-20 | Hsiang Lan Wu Liu | Decorative lantern |
JP4667369B2 (ja) * | 2003-03-21 | 2011-04-13 | ネックスメド ホールディングス インコーポレイテッド | 早漏を治療するための組成物および方法 |
GB0409744D0 (en) * | 2004-04-30 | 2004-06-09 | Pfizer Ltd | Novel compounds |
-
2008
- 2008-10-27 KR KR1020080105439A patent/KR101103118B1/ko not_active IP Right Cessation
- 2008-10-29 CL CL2008003231A patent/CL2008003231A1/es unknown
- 2008-10-31 NZ NZ585091A patent/NZ585091A/en not_active IP Right Cessation
- 2008-10-31 MX MX2010004727A patent/MX2010004727A/es active IP Right Grant
- 2008-10-31 UA UAA201006496A patent/UA99492C2/ru unknown
- 2008-10-31 WO PCT/KR2008/006445 patent/WO2009057974A2/en active Application Filing
- 2008-10-31 CA CA2703783A patent/CA2703783C/en not_active Expired - Fee Related
- 2008-10-31 TW TW097142052A patent/TWI365741B/zh not_active IP Right Cessation
- 2008-10-31 CN CN2008801224430A patent/CN101910146A/zh active Pending
- 2008-10-31 US US12/739,870 patent/US8242159B2/en not_active Expired - Fee Related
- 2008-10-31 EP EP08846179A patent/EP2215070A4/en not_active Withdrawn
- 2008-10-31 PE PE2008001868A patent/PE20091018A1/es not_active Application Discontinuation
- 2008-10-31 RU RU2010122320/04A patent/RU2448963C2/ru not_active IP Right Cessation
- 2008-10-31 JP JP2010531967A patent/JP5281649B2/ja not_active Expired - Fee Related
- 2008-10-31 AU AU2008319628A patent/AU2008319628B2/en not_active Ceased
- 2008-10-31 BR BRPI0818267-1A patent/BRPI0818267A2/pt not_active IP Right Cessation
- 2008-11-03 AR ARP080104804A patent/AR069166A1/es not_active Application Discontinuation
-
2010
- 2010-04-26 IL IL205350A patent/IL205350A0/en unknown
- 2010-05-27 ZA ZA2010/03794A patent/ZA201003794B/en unknown
- 2010-06-02 CO CO10066630A patent/CO6280531A2/es active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
EP2215070A2 (en) | 2010-08-11 |
EP2215070A4 (en) | 2011-11-02 |
KR101103118B1 (ko) | 2012-01-04 |
JP5281649B2 (ja) | 2013-09-04 |
TW200934481A (en) | 2009-08-16 |
NZ585091A (en) | 2012-04-27 |
ZA201003794B (en) | 2011-02-23 |
KR20090045855A (ko) | 2009-05-08 |
BRPI0818267A2 (pt) | 2015-04-14 |
RU2448963C2 (ru) | 2012-04-27 |
US8242159B2 (en) | 2012-08-14 |
WO2009057974A2 (en) | 2009-05-07 |
TWI365741B (en) | 2012-06-11 |
AU2008319628B2 (en) | 2012-03-29 |
RU2010122320A (ru) | 2011-12-10 |
US20100240725A1 (en) | 2010-09-23 |
UA99492C2 (ru) | 2012-08-27 |
MX2010004727A (es) | 2010-05-20 |
CA2703783C (en) | 2012-12-04 |
CN101910146A (zh) | 2010-12-08 |
JP2011502981A (ja) | 2011-01-27 |
IL205350A0 (en) | 2010-12-30 |
AU2008319628A1 (en) | 2009-05-07 |
PE20091018A1 (es) | 2009-08-17 |
CA2703783A1 (en) | 2009-05-07 |
AR069166A1 (es) | 2010-01-06 |
CL2008003231A1 (es) | 2009-11-27 |
WO2009057974A3 (en) | 2009-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO6280531A2 (es) | Novedosos derivados de 1,3 | |
NO20075299L (no) | Hydrogenated benzo (c) thiophene derivatives as immunomodulators | |
AR112074A2 (es) | Derivados de 2-carboxamida-cicloamino-urea como inhibidores de pi-3 | |
MX2007012090A (es) | Derivados sustituidos de pirazoliloxifenilo como herbicidas. | |
NO20076648L (no) | Novel thiophene derivatives | |
IL208636A0 (en) | Spirocyclic derivatives as histone deacetylase inhibitors | |
HK1112909A1 (en) | Phenyl-{3-(3-(1h-pyrrol-2-yl)-[1,2,4]oxadiazol-5-yl]piperidin-1-yl}- methanone derivatives and related compounds as positive allosteric modulators of metabotropic glutamate receptors | |
NO20082579L (no) | Aza-substituert spiroderivat | |
NO20082561L (no) | Nye koblede pyrrolderivater | |
MX2010009284A (es) | Composicion para uso agricola para controlar o prevenir enfermedades vegetales provocadas por patogenos vegetales. | |
HRP20120323T1 (en) | Diarylhydantoin compounds | |
EA200801959A1 (ru) | Высокоразветвленный полипропилен | |
CO5560567A2 (es) | Comuestos que contienen lactama y sus derivados como inhibidores de factor xa | |
NO20076478L (no) | Substituerte oksadiazolderivater som positive allosteriske modulatorer av metabotrope glutamatreseptorer | |
UA103350C2 (en) | Container | |
MX2013003034A (es) | Lactamas piperidinilo-substituidas como moduladores de gpr119. | |
CO6251288A2 (es) | Novedosas fenilpirrolidinas disustuidas como moduladores de la neurotransmision catecolaminergica cortical | |
UY30387A1 (es) | Nuevos compuestos | |
WO2011010084A3 (en) | Cyclosporin conjugates | |
WO2007017728A3 (en) | Novel heterocyclic compounds | |
IN2012DN00765A (es) | ||
WO2009011270A1 (ja) | トリアジン環含有高分子化合物および該高分子化合物を用いた有機発光素子 | |
MX2009006334A (es) | Derivados de heteroaril-pirrolidinil- y -piperidinil-cetona. | |
MX2011011080A (es) | Antagonistas de ccr3 de arilsulfonamida 2, 5-disustituida. | |
EP2036905A4 (en) | PYRIDYLISOXAZOLE DERIVATIVE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Application granted |